T CELL RECEPTORS INVOLVED IN TMEV INDUCED DEMYELINATION
T 细胞受体参与 TMEV 诱导的脱髓鞘
基本信息
- 批准号:6051065
- 负责人:
- 金额:$ 22.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-05-01 至 2004-03-31
- 项目状态:已结题
- 来源:
- 关键词:SDS polyacrylamide gel electrophoresis T cell receptor active immunization autoantibody autoantigens autoimmune disorder chronic disease /disorder cytokine disease /disorder etiology disease /disorder model enzyme linked immunosorbent assay epitope mapping genetically modified animals hybridomas inflammation injection /infusion laboratory mouse major histocompatibility complex murine encephalomyelitis virus myelin proteolipid neuropathology neuroprotectants tissue /cell culture viral myelinopathy
项目摘要
Intracerebral inoculation of Theiler's murine encephalomyelitis virus (TMEV) results in chronic inflammatory demyelination leading to clinical signs in susceptible mice. The TMEV system is considered to be a relevant infectious animal model, an alternative to the experimental autoimmune encephalomyelitis (EAE) system, for studying human multiple sclerosis (MS) in light of the potential viral etiology and similarities in the progression of chronic demyelination. Previously, we have identified major Th epitopes accounting for greater than 85 percent of the Th response to TMEV. In addition, we have identified the Th epitopes (VP1233-250 and VP274-86, but not VP324-37) involved in the pathogenesis of demyelination and their association to induce relatively high levels of Th responses. We have further observed that the Jbeta1 region polymorphism is associated with susceptibility to demyelination and that the susceptible H-2Ds MHC locus can override the resistant effect of the TCR beta-chain genotype. Furthermore, we have recently selected spontaneously arising non-pathogenic variant viruses containing a single amino acid substitution at position 244 within the major Th1 epitope, VP1233-250, resulting in a switch to Th2 response. Moreover, the initial demyelination induced by TMEV infection leads to the development of autoimmune Th response to a major myelin component. Our recent preliminary studies for spectratyping and TCR CDR3 analyses of infiltrating T cells in the CNS indicate that clonal expansion of certain T cell populations is apparent as early as 7 d after viral infection. Some of the major population appear to be persistent throughout the disease course. In comparison with CDR3 sequences of hybridomas with known specificity, these T cells represent virus- and/or autoantigen-reactive populations. Based on these preliminary results, we propose to correlate the TCR repertoire in the CNS with the development of TMEV-induced demyelination. Three specific aims are proposed in this application: (1) Correlation of the TCR repertoire in the CNS with the pathogenesis of TMEV-induced demyelination; (2) Role of virus- specific and autoreactive T cells in the pathogenesis of demyelination; and (3) Influence of additional Vbeta or resistant MHC class I genes in the selection of TCR repertoire in the CNS. We believe that our proposed studies will yield important information on the role of infiltrating T cell populations and their expansion in the pathogenesis of virus-induced, T cell-mediated demyelination, leading to the eventual development of autoimmunity to CNS autoantigens.
脑内接种Theiler小鼠脑脊髓炎病毒(TMEV)导致慢性炎性脱髓鞘,导致易感小鼠出现临床体征。 TMEV系统被认为是一种相关的感染性动物模型,可替代实验性自身免疫性脑脊髓炎(EAE)系统,用于研究人类多发性硬化症(MS)的潜在病毒病因学和慢性脱髓鞘进展的相似性。 以前,我们已经确定了主要的Th表位占超过85%的Th反应TMEV。 此外,我们已经确定了Th表位(VP 1233 -250和VP 274 -86,但不是VP 324 -37)参与脱髓鞘的发病机制和它们的关联,以诱导相对高水平的Th反应。 我们进一步观察到,Jbeta 1区域多态性与脱髓鞘的易感性相关,易感的H-2Ds MHC基因座可以覆盖TCR β链基因型的耐药效应。 此外,我们最近选择了自发产生的非致病性变异病毒,其在主要Th 1表位VP 1233 -250内的位置244处含有单个氨基酸取代,导致向Th 2应答的转换。 此外,由TMEV感染诱导的初始脱髓鞘导致对主要髓鞘组分的自身免疫Th应答的发展。 我们最近对CNS中浸润性T细胞的光谱分析和TCR CDR 3分析的初步研究表明,某些T细胞群体的克隆扩增早在病毒感染后7天就很明显。一些主要人群似乎在整个病程中持续存在。 与具有已知特异性的杂交瘤的CDR 3序列相比,这些T细胞代表病毒和/或自身抗原反应性群体。 基于这些初步的结果,我们建议相关的TCR库在中枢神经系统的发展TMEV诱导的脱髓鞘。在本申请中提出了三个具体目的:(1)CNS中TCR库与TMEV诱导的脱髓鞘的发病机制的相关性;(2)病毒特异性和自身反应性T细胞在脱髓鞘的发病机制中的作用;和(3)另外的V β或抗性MHC I类基因在CNS中TCR库的选择中的影响。我们相信,我们提出的研究将产生重要的信息的作用,浸润的T细胞群体和他们的扩张的发病机制中的病毒诱导的,T细胞介导的脱髓鞘,导致最终发展的自身免疫CNS自身抗原。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BYUNG S KIM其他文献
BYUNG S KIM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BYUNG S KIM', 18)}}的其他基金
Role of CD8+ T Cells in TMEV Resistance and Susceptibili
CD8 T 细胞在 TMEV 耐药性和易感性中的作用
- 批准号:
6562284 - 财政年份:2002
- 资助金额:
$ 22.74万 - 项目类别:
IMMUNOGENETICS OF RESISTANCE/SUSCEPTIBILITY TO TMEV INDUCED DEMYELINATION
对 TMEV 引起的脱髓鞘的耐药性/敏感性的免疫遗传学
- 批准号:
6565215 - 财政年份:2001
- 资助金额:
$ 22.74万 - 项目类别:
IMMUNOGENETICS OF RESISTANCE/SUSCEPTIBILITY TO TMEV INDUCED DEMYELINATION
对 TMEV 引起的脱髓鞘的耐药性/敏感性的免疫遗传学
- 批准号:
6410633 - 财政年份:2000
- 资助金额:
$ 22.74万 - 项目类别:
IMMUNOGENETICS OF RESISTANCE/SUSCEPTIBILITY TO TMEV INDUCED DEMYELINATION
对 TMEV 引起的脱髓鞘的耐药性/敏感性的免疫遗传学
- 批准号:
6302773 - 财政年份:1999
- 资助金额:
$ 22.74万 - 项目类别:
IMMUNOGENETICS OF RESISTANCE/SUSCEPTIBILITY TO TMEV INDUCED DEMYELINATION
对 TMEV 引起的脱髓鞘的耐药性/敏感性的免疫遗传学
- 批准号:
6112251 - 财政年份:1998
- 资助金额:
$ 22.74万 - 项目类别:
IMMUNOGENETICS OF RESISTANCE/SUSCEPTIBILITY TO TMEV INDUCED DEMYELINATION
对 TMEV 引起的脱髓鞘的耐药性/敏感性的免疫遗传学
- 批准号:
6273739 - 财政年份:1997
- 资助金额:
$ 22.74万 - 项目类别:
Role of CNS CD4+ T cells in TMEV-induced Demyelination
CNS CD4 T 细胞在 TMEV 诱导的脱髓鞘中的作用
- 批准号:
7114307 - 财政年份:1994
- 资助金额:
$ 22.74万 - 项目类别:
Role of CNS CD4+ T cells in TMEV-induced Demyelination
CNS CD4 T 细胞在 TMEV 诱导的脱髓鞘中的作用
- 批准号:
6869030 - 财政年份:1994
- 资助金额:
$ 22.74万 - 项目类别:
Role of CNS CD4+ T cells in TMEV-induced Demyelination
CNS CD4 T 细胞在 TMEV 诱导的脱髓鞘中的作用
- 批准号:
7503372 - 财政年份:1994
- 资助金额:
$ 22.74万 - 项目类别:
T-CELL RECEPTORS INVOLVED IN TMEV-INDUCED DEMYELINATION
T 细胞受体参与 TMEV 诱导的脱髓鞘
- 批准号:
2271542 - 财政年份:1994
- 资助金额:
$ 22.74万 - 项目类别:
相似海外基金
The molecular basis of T cell receptor cross-reactivity between MHC and MR1
MHC 和 MR1 之间 T 细胞受体交叉反应的分子基础
- 批准号:
DP240102905 - 财政年份:2024
- 资助金额:
$ 22.74万 - 项目类别:
Discovery Projects
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23K28188 - 财政年份:2024
- 资助金额:
$ 22.74万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
CAREER: Understanding the Impact of Dephosphorylation Kinetics and Adapter Specificity on Synthetic T Cell Receptor Signaling and Function
职业:了解去磷酸化动力学和接头特异性对合成 T 细胞受体信号传导和功能的影响
- 批准号:
2339172 - 财政年份:2024
- 资助金额:
$ 22.74万 - 项目类别:
Continuing Grant
Special Public T Cell Receptor Sequences that Predict Outcomes for Cancer Patients
预测癌症患者预后的特殊公共 T 细胞受体序列
- 批准号:
10577518 - 财政年份:2023
- 资助金额:
$ 22.74万 - 项目类别:
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23H03498 - 财政年份:2023
- 资助金额:
$ 22.74万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Impact of T cell receptor signaling on memory CD8+ T cell stemness
T 细胞受体信号传导对记忆 CD8 T 细胞干性的影响
- 批准号:
10676407 - 财政年份:2023
- 资助金额:
$ 22.74万 - 项目类别:
T cell receptor cross-reactivity and structural basis of virus immune escape
T细胞受体交叉反应性和病毒免疫逃逸的结构基础
- 批准号:
22KK0277 - 财政年份:2023
- 资助金额:
$ 22.74万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy
使用体内新型免疫原策略生成 T 细胞受体模拟亲和试剂
- 批准号:
10599584 - 财政年份:2023
- 资助金额:
$ 22.74万 - 项目类别:
Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
- 批准号:
10530023 - 财政年份:2022
- 资助金额:
$ 22.74万 - 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
- 批准号:
10684172 - 财政年份:2022
- 资助金额:
$ 22.74万 - 项目类别: